Log in to save to my catalogue

A new fully liquid presentation of MenACWY-CRM conjugate vaccine: Results from a multicentre, random...

A new fully liquid presentation of MenACWY-CRM conjugate vaccine: Results from a multicentre, random...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_2582569594

A new fully liquid presentation of MenACWY-CRM conjugate vaccine: Results from a multicentre, randomised, controlled, observer-blind study

About this item

Full title

A new fully liquid presentation of MenACWY-CRM conjugate vaccine: Results from a multicentre, randomised, controlled, observer-blind study

Publisher

Netherlands: Elsevier Ltd

Journal title

Vaccine, 2021-10, Vol.39 (45), p.6628-6636

Language

English

Formats

Publication information

Publisher

Netherlands: Elsevier Ltd

More information

Scope and Contents

Contents

Highlights•A new fully liquid version of the MenACWY-CRM conjugate vaccine has been developed. •The serogroup A component was modified from lyophilised to liquid presentation. •Liquid vaccine was non-inferior to licensed vaccine in immune response against MenA. •Immune responses against other serogroups were similar with both presentations. •The re...

Alternative Titles

Full title

A new fully liquid presentation of MenACWY-CRM conjugate vaccine: Results from a multicentre, randomised, controlled, observer-blind study

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_journals_2582569594

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_2582569594

Other Identifiers

ISSN

0264-410X

E-ISSN

1873-2518

DOI

10.1016/j.vaccine.2021.09.068

How to access this item